SSY Group Ltd. | Mutual Funds
Mutual Funds that own SSY Group Ltd.
UBS (Lux) Equity Fund - China Opportunity
93,893,447
3.12%
2,682,000
2.33%
01/31/2018
UBS (Lux) Equity Fund - Greater China
30,055,066
1%
-1,156,000
3.44%
01/31/2018
Government Pension Fund - Global (The)
27,509,472
0.91%
2,344,072
0%
12/31/2017
Vanguard Total International Stock Index Fund
19,908,894
0.66%
0
0.01%
07/31/2018
Fidelity Funds SICAV - China Consumer
19,468,133
0.65%
154
0.68%
05/31/2018
Vanguard Emerging Markets Stock Index Fund
18,914,000
0.63%
-140,000
0.02%
07/31/2018
iShares Core MSCI Emerging Markets ETF
18,796,411
0.62%
0
0.04%
09/05/2018
DFA Emerging Markets Core Equity Portfolio
15,404,506
0.51%
0
0.05%
04/30/2018
DFA Emerging Markets Small Cap Series
13,919,152
0.46%
0
0.18%
01/31/2018
Nordea Emerging Market Equities
10,126,641
0.34%
36,494
0.52%
05/31/2018
| Address |
Rooms 4902-03, 49th Floor
Hong Kong
Hong Kong
|
|
Employees
|
- |
| Website |
http://www.ssygroup.com.hk |
| Updated |
07/08/2019 |
| SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. It operates through the following segments: Intravenous Infusion Solution and Others; and Medical Materials. The company was founded on September 28, 2004 and is headquartered in Hong Kong. |
